Morgan Stanley’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-316,313
Closed -$380K 7790
2023
Q2
$380K Sell
316,313
-119,039
-27% -$146K ﹤0.01% 5354
2023
Q1
$662K Sell
435,352
-146,118
-25% -$550K ﹤0.01% 5095
2022
Q4
$2.19M Buy
581,470
+161,504
+38% +$854K ﹤0.01% 4399
2022
Q3
$2.09M Sell
419,966
-42,567
-9% -$239K ﹤0.01% 4395
2022
Q2
$2.15M Buy
462,533
+330,670
+251% +$2.02M ﹤0.01% 4485
2022
Q1
$991K Buy
131,863
+37,658
+40% +$305K ﹤0.01% 5005
2021
Q4
$833K Buy
94,205
+13,506
+17% +$138K ﹤0.01% 5202
2021
Q3
$816K Buy
80,699
+62,430
+342% +$705K ﹤0.01% 5183
2021
Q2
$312K Sell
18,269
-932
-5% -$15.7K ﹤0.01% 5784
2021
Q1
$344K Buy
+19,201
New +$398K ﹤0.01% 5360

Other funds holding PTRA

Morgan Stanley's PTRA Position: Q3 2023 in Review

Morgan Stanley sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 316,313 shares — an estimated $380K sold.

Morgan Stanley first reported a position in PTRA in Q1 2021 and held it in 10 quarters. The position peaked at $2.19M in Q4 2022. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • Morgan Stanley reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 316,313 Proterra Inc. Common Stock shares in Q3 2023, an estimated $380K.
  • Morgan Stanley first reported a position in Proterra Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Morgan Stanley's Proterra Inc. Common Stock position peaked at $2.19M in Q4 2022.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.